Antibacterial and antibiotic synergistic activities of the extract from Pithecellobium clypearia against clinically important multidrug-resistant gram-negative bacteria
ConclusionsS20b increased the efficiency of antibiotics against MDRAB and MDRPsA. This study is the first to demonstrate that S20b from Pithecellobium clypearia may have potential use as a therapeutic agent to against MDRAB and MDRPsA.
Source: European Journal of Integrative Medicine - Category: Complementary Medicine Source Type: research
More News: Acinetobacter | China Health | Complementary Medicine | Herbs | Multidrug Resistance | Study